The Duralast 30 tablet treats premature ejaculation (PE), a common sexual disorder affecting many men worldwide. Premature ejaculation is the inability to control or delay ejaculation during sexual intercourse, causing distress and anxiety. This condition affects approximately 1 in 3 men and can lead to problems in relationships and affect self-esteem.
Duralast 30 tablet is a selective serotonin reuptake inhibitor (SSRI) medication that increases serotonin levels in the brain.
The Duralast 30 tablet is available in a convenient tablet form, each containing 30 mg of the active ingredient, dapoxetine. This medication is intended for men aged 18 to 64 who experience premature ejaculation. It is not recommended for use in women and men who do not suffer from premature ejaculation.
Clinical studies have shown that the Duralast 30 tablet can significantly improve the time to ejaculation and overall sexual satisfaction in men with premature ejaculation. The medication is safe and effective when used as directed, with minimal side effects.
It is important to note that Duralast 30 tablets should only be used as directed by a healthcare professional. It is not intended for long-term use or as a treatment for other sexual disorders. Men who experience premature ejaculation should consult a healthcare provider to determine the underlying cause and develop an appropriate treatment plan.